Skip to main content

Table 2 PERCIST1.0 versus RECIST1.1 response

From: FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

Characteristic

PERCIST1.0 response

Total (n = 15)

CMR (n = 11)

SMD (n = 2)

PMD (n = 2)

RECIST1.1 response, n(%)

 CR

1 (9%)

0

0

1 (7%)

 PR

9 (82%)

2 (100%)

0

11 (73%)

 SD

1 (9%)

0

0

1 (7%)

 PD

0

0

2 (100%)

2 (13%)

  1. CMR complete metabolic response, CR complete response, PMD progressive metabolic disease, PMR partial metabolic response, PR partial response, SD stable disease, SMD stable metabolic disease
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us